Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-07-31

FDA Approved: COSOPT — Supplemental Application (Thea Pharma Inc.)

View source ↗

Summary

FDA approved a supplemental application for COSOPT (dorzolamide hydrochloride and timolol maleate) submitted by Thea Pharma Inc. The product is used to lower in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cosopt (dorzolamide/timolol)

Snippet

SUPPL AP for COSOPT (DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE)